Collins Says NIH March-In-Rights Do Not Apply In Cases Of High Prices

NIH head Francis Collins threw cold water on advocates' and lawmakers' calls for the agency to utilize its so-called march-in rights created by the Bayh-Dole Act in response to high drug prices. The agency head said the law only applies in cases when the tax-payer funded drugs are not available whatsoever. Under the act, when taxpayer-funded research is used in part to develop a new patent, the agency that helped develop the patent can require it be licensed to a...